Popular Weight Loss Drugs No Longer in Shortage; FDA to Limit Cheaper Alternatives
By Chase Smith The FDA has officially removed popular weight loss drugs, including Lilly’s Mounjaro and Zepbound, from its drug shortage list, signaling the end of a nearly two-year period of scarcity that allowed compounding pharmacies to produce more affordable versions of these medications. “FDA confirmed with the drug’s manufacturer that their stated product availability and…
More Stories
A Long Dockworker Strike May Bring More Pain to Consumers at the Grocery Store
By Mark Gilman Food prices went up 25 percent from 2019 to 2023 and were expected to increase by another...
High New Car Prices Spur Increased Incentives, but End of Low Cost Sedan Is Affecting Buyer Enthusiasm
By Mark Gilman If you’re in the market for an inexpensive second car, a first car for a family member,...
MFS Government Markets Income Trust (NYSE:MGF) Increases Dividend to $0.02 Per Share
MFS Government Markets Income Trust (NYSE:MGF – Get Free Report) declared a monthly dividend on Tuesday, October 1st, Wall Street...
Eaton Vance California Municipal Bond Fund (NYSE:EVM) Declares Monthly Dividend of $0.04
Eaton Vance California Municipal Bond Fund (NYSE:EVM – Get Free Report) announced a monthly dividend on Tuesday, October 1st, Wall...
Nuveen New York Select Tax-Free Income Portfolio (NXN) To Go Ex-Dividend on October 15th
Nuveen New York Select Tax-Free Income Portfolio (NYSE:NXN – Get Free Report) declared a monthly dividend on Tuesday, October 1st,...
Nuveen Select Tax-Free Income Portfolio Announces Monthly Dividend of $0.05 (NYSE:NXP)
Nuveen Select Tax-Free Income Portfolio (NYSE:NXP – Get Free Report) announced a monthly dividend on Tuesday, October 1st, Wall Street...